In vivo inactivation of formylglycinamidine ribonucleotide synthetase in rat hepatoma
- 1 January 1985
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 34 (2) , 243-248
- https://doi.org/10.1016/0006-2952(85)90131-5
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Control of enzymic programs and nucleotide pattern in cancer cells by acivicin and tiazofurinAdvances in Enzyme Regulation, 1984
- Salvage capacity of hepatoma 3924A and action of dipyridamoleAdvances in Enzyme Regulation, 1983
- Multi-enzyme-targeted chemotherapy by acivicin and actinomycinAdvances in Enzyme Regulation, 1982
- In vivo inactivation by acivicin of carbamoylphosphate synthetase II in rat hepatomaBiochemical Pharmacology, 1982
- Guanosine-5′-phosphate synthetase and guanosine-5′-phosphate kinase in rat hepatomas and kidney tumorsBiochimica et Biophysica Acta (BBA) - Enzymology, 1981
- Studies of the biochemical pharmacology of the fermentation-derived antitumor agent, (αS, 5S) -α-amino-3-chloro-4, 5-dihydro-5-isoxazoleacetic acid (at-125)Advances in Enzyme Regulation, 1979
- The isolation, structure, and absolute configuration of U-42,126 a novel antitumor antibioticTetrahedron Letters, 1973
- Bromopyruvate Inactivation of 2-Keto-3-deoxy-6-phosphogluconic Aldolase. I. Kinetic Evidence for Active Site Specificity*Biochemistry, 1967